Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Evaluate the Safety of Twice Daily Oral Carvedilol

ClinicalTrials.gov ID: NCT00129363

Public ClinicalTrials.gov record NCT00129363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open Label Extension Study to Evaluate the Safety of Twice Daily Oral Carvedilol in Pediatric Patients With Chronic Heart Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the long-term safety of carvedilol in pediatric patients with chronic heart failure, who completed the Pediatric Carvedilol Study 321. Carvedilol will be provided as open-label therapy for a period of at least 6 months (or until termination of the study) by SmithKline Beecham Corporation d/b/a GlaxoSmithKline (GSK) or the University Sponsor.

Study identification

NCT ID
NCT00129363
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shaddy, Robert, M.D.
Individual
Enrollment
75 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Day to 17 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2002 (Type not available)
Primary completion
Jan 2006 (Actual)
Completion
Jan 2006 (Actual)
Last update posted
Dec 25, 2008

2002 – 2006

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Mattel Children's Hospital at UCLA Los Angeles California 90025 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Stanford University Palo Alto California 94303 —
University of Colorado Denver Colorado 80218 —
University of Miami Miami Florida 33101 —
Children's Memorial Hospital Chicago Illinois 60614 —
Children's Hospital, Boston Boston Massachusetts 02115 —
C.S. Mott Children's Hospital Ann Arbor Michigan 48109 —
Children's Hospital of Michigan Detroit Michigan 48201-2196 —
Washington University St Louis Missouri 63110-1014 —
Columbia University New York New York 10032-1537 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Vanderbilt Children's Hospital Nashville Tennessee 37332 —
UT Southwestern Medical Center Dallas Texas 75235-7794 —
Texas Children's Hospital Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
Seattle Childrens Hospital and Regional Medical Center Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00129363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 25, 2008 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00129363 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →